These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 3995528

  • 21. Short-term and long-term open evaluation of the efficacy and tolerance of proglumetacin, a new antirheumatic agent.
    Branco do Amaral A.
    Pharmatherapeutica; 1982; 3(3):174-9. PubMed ID: 6982478
    [Abstract] [Full Text] [Related]

  • 22. [Gout: current views. Stage oriented treatment].
    Fedorova NE, Grigor'eva VD.
    Klin Med (Mosk); 2002; 80(2):9-13. PubMed ID: 11898731
    [Abstract] [Full Text] [Related]

  • 23. Preliminary double-blind evaluation of a new, non-steroidal anti-inflammatory drug: protacine.
    Münzenberg J, Tachibana S.
    Pharmatherapeutica; 1980; 2(5):279-84. PubMed ID: 7001486
    [Abstract] [Full Text] [Related]

  • 24. [Treatment of acute uric arthritis using Perclusone].
    Cunović S.
    Reumatizam; 1973; 20(4):156-9. PubMed ID: 4731458
    [No Abstract] [Full Text] [Related]

  • 25. Treatment of acute gouty arthritis with piroxicam.
    Karachalios GN.
    Clin Exp Rheumatol; 1985; 3(1):63-5. PubMed ID: 2579757
    [Abstract] [Full Text] [Related]

  • 26. Fentiazac in osteoarthritis: comparison of BID and QID regimens.
    Molina-López J.
    Clin Ther; 1983; 5(5):462-71. PubMed ID: 6604579
    [Abstract] [Full Text] [Related]

  • 27. [Treatment of inflammatory disease of the prostate with non-steroid anti-inflammatory agents].
    Simon J, Schulman CC.
    Acta Urol Belg; 1983; 51(4):532-7. PubMed ID: 6196959
    [No Abstract] [Full Text] [Related]

  • 28. Etodolac, aspirin, and placebo in patients with degenerative joint disease: a twelve-week study.
    Andelman SY.
    Clin Ther; 1983; 5(6):651-61. PubMed ID: 6226358
    [Abstract] [Full Text] [Related]

  • 29. Treatment of acute gouty arthritis with proquazone and indomethacin. A comparative, double-blind trial.
    Ruotsi A, Vainio U.
    Scand J Rheumatol Suppl; 1978; (21):15-7. PubMed ID: 356235
    [Abstract] [Full Text] [Related]

  • 30. [Current treatment of hyperuricemia and gout].
    Vukotić D.
    Med Pregl; 1982; 35(5-6):213-7. PubMed ID: 7177063
    [No Abstract] [Full Text] [Related]

  • 31. Gouty arthritis in acute cerebrovascular disease.
    Lin YH, Hsu HL, Huang YC, Lee M, Huang WY, Huang YC, Lee TH, Lee JD.
    Cerebrovasc Dis; 2009; 28(4):391-6. PubMed ID: 19696479
    [Abstract] [Full Text] [Related]

  • 32. Comparative efficacy of etodolac and placebo in rheumatoid arthritic patients.
    Vetter G, Placchi M, Joubert L.
    Int J Clin Pharmacol Ther Toxicol; 1982 May; 20(5):240-5. PubMed ID: 6212555
    [Abstract] [Full Text] [Related]

  • 33. [Proglumetacin for a wide spectrum of activity in clinical medicine].
    Fossaluzza V.
    Minerva Med; 1983 Jun 23; 74(26):1529-33. PubMed ID: 6856164
    [Abstract] [Full Text] [Related]

  • 34. The treatment of inflammatory arthritis with methotrexate in clinical practice: treatment duration and incidence of adverse drug reactions.
    Kinder AJ, Hassell AB, Brand J, Brownfield A, Grove M, Shadforth MF.
    Rheumatology (Oxford); 2005 Jan 23; 44(1):61-6. PubMed ID: 15611303
    [Abstract] [Full Text] [Related]

  • 35. [Polyarticular gout--change in the clinical picture?].
    Becker-Capeller D, Helker K, Weber MH.
    Z Arztl Fortbild (Jena); 1996 May 23; 90(3):227-31. PubMed ID: 8779236
    [Abstract] [Full Text] [Related]

  • 36. A comparative study of the antiinflammatory activity of fentiazac and its major metabolite, p-hydroxy fentiazac.
    Chang J, Carlson RP, Lewis AJ.
    Agents Actions; 1984 Oct 23; 15(3-4):443-7. PubMed ID: 6441470
    [Abstract] [Full Text] [Related]

  • 37. Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: a twenty-eight-day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout.
    Becker MA, Schumacher HR, Wortmann RL, MacDonald PA, Palo WA, Eustace D, Vernillet L, Joseph-Ridge N.
    Arthritis Rheum; 2005 Mar 23; 52(3):916-23. PubMed ID: 15751090
    [Abstract] [Full Text] [Related]

  • 38. [The use of fentiazac in the therapy of primary dysmenorrhea].
    Rendina GM, Patrono D, Iansiti A.
    Minerva Ginecol; 1982 May 23; 34(5):395-400. PubMed ID: 6982435
    [No Abstract] [Full Text] [Related]

  • 39. Development of acute gouty attack in the morbidly obese population after bariatric surgery.
    Antozzi P, Soto F, Arias F, Carrodeguas L, Ropos T, Zundel N, Szomstein S, Rosenthal R.
    Obes Surg; 2005 Mar 23; 15(3):405-7. PubMed ID: 15826477
    [Abstract] [Full Text] [Related]

  • 40. [The effectiveness and safety of nimesulide (nimesile) in patients with gouty arthritis].
    Barskova VG, Nasonova VA, Tsapina TN, Karateev AE, Iakunina IA, Eliseev MS, Il'inykh EV, Nasonov EL.
    Klin Med (Mosk); 2004 Mar 23; 82(12):49-54. PubMed ID: 15732721
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.